Viedoc is a winner of Category Awards in both Innovation and Product Launches in the 2023 Pharmaceutical Technology Excellence Awards due to the success and innovative features of its electronic data capture (EDC) software platform.
Since 2003, Viedoc’s eClinical solution has been used to power over 5,000 studies, collecting data from over 1 million patients and enabling it to flow smoothly and securely across some 30,000 sites and 75 countries. The Viedoc solution is designed to revolutionize pharmaceutical research by making the activities and tasks of researchers easier, faster, and more enjoyable.
Go deeper with GlobalData
Viedoc participates actively in the global clinical trials industry. The company hosted an exclusive event in January 2023 with the European Parliament on the future of clinical trials and health data in Europe in association with the Society for Clinical Data Management (SCDM) and innovation incubator Re-Imagine Europa.
At the heart of Viedoc’s offering is Innovation. The company’s products are recognized in this category for its wide range of features that streamline participation in clinical trials and enhance collaboration via a user-friendly interface and mobile accessibility for data capture capabilities in areas with limited access to trial sites.
The company’s solution offers seamless integration with other systems and boasts advanced data import/export capabilities to streamline data flow.
Additional critical elements of Viedoc’s platform include its robust security measures to protect sensitive patient data, compliance with international regulatory standards, and audit trail functionality to track and document data changes.
Viedoc has gained recognition in the Product Launches category this year due to its consistent and incremental updates to the platform. Its comprehensive user-interface-optimization project has reimagined how users interact with data.
The platform offers visualizations and reports, modern drag-and-drop study design, and newly refined eCOA/ePRO features, all through an interface that takes inspiration from modern, cutting-edge applications.
Viedoc has also created many features supporting decentralised clinical trials (DCTs). These include seamlessly integrated video calls that strengthen virtual collaboration between patients and researchers, personalized messages and views, notifications, and auto-reminders.
Viedoc’s emphasis on product development has led to a solid vendor reputation with a track record of successful implementations, training, technical support, and regular software updates.
The platform’s success can be seen through the company’s growth in the market, with sales growth of 81% during the research period, an equivalent of 50% YoY. Moreover, Viedoc has amplified its global footprint by targeting the US market and showcasing its brand at international trade shows, industry roundtables, and leading global events.
In June 2023, Viedoc was placed at the top of the EDC segment by peer-to-peer review site G2. It received special recognition for its unparalleled customer focus, underscored by its net customer retention rate, which surged to 125%.
In addition, Viedoc received four Global Data awards for Marketing, Business Expansion, Innovation, and Product Launches in the 2023 Clinical Trials Arena Excellence Awards.
These remarkable achievements and recognition at the 2023 Pharmaceutical Technology Excellence Awards underscore Viedoc’s pivotal role in reshaping the future of pharmaceutical research.
Contact details
Stationsgatan 23,
Uppsala, Sweden
Links
